[1]
Kishishita, J. et al. 2017. TOPICAL USE OF CIDOFOVIR FOR THE TREATMENT OF LESIONS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS: A LITERATURE REVIEW. Infarma - Pharmaceutical Sciences. 29, 1 (Apr. 2017), 13–20. DOI:https://doi.org/10.14450/2318-9312.v29.e1.a2017.pp13-20.